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A severe regenerative anemia was detected in a 12-week-old mixed breed puppy in Sweden.
A small protozoan parasite was observed in erythrocytes on a blood smear. It was initially suspected to be Babesia
gibsoni based on its size and because B. gibsoni was previously recorded in Sweden.
Surprisingly, specific polymerase chain reaction analysis identified the protozoan as Theileria annae. T. annae is
endemic in Northwest Spain, is very uncommonly reported elsewhere and has never been recorded in Scandinavia.
T. annae has been identified in dogs used for dog fighting, and it is thought to be transmitted by dog bites. This
puppy was a mixed pit bull terrier. Pit bull terriers are sometimes used for dog fighting. T. annae has been reported
to be transmitted vertically, and in light of the puppy’s age, this transmission was suspected in the present case.
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Several blood parasites, such as Babesia spp., infect erythro-
cytes in dogs and may lead to hemolytic anemia. Babesiosis
in domestic dogs and wild canids is caused by several
vector-borne, geographically widespread hemoprotozoan
parasites belonging to the Babesia and Theileria genera,
and the most commonly reported species in Europe include
B. canis, B. gibsoni, B. vogeli and T. annae [1,2]. T. annae
is also called Babesia microti-like or Spanish isolate/agent
because it is endemic in Galicia, Northwestern Spain. T.
annae has also been identified in Portugal, Croatia and in
one dog in North America [2-7]. Ixodes hexagonus is the
likely vector of T. annae in Northwest Spain, but other
ticks such as Rhipicephalus sanguineus, Ixodes ricinus and
Dermacentor spp. have also been proposed as possible
transmitters [2,8,9]. A vertical (transplacental) transmis-
sion of T. annae is also likely as it has been detected in a
German shepherd bitch and her 2-month old pup [7]. T.
annae has also been detected in a dog confiscated from
dogfighting operations in North America suggesting that
T. annae may be transmitted by dog bites as occurs with
B. gibsoni [6].
T. annae causes severe illness, and dogs may present
with weakness, fever, lethargy, hemoglobinuria, tachycar-
dia and tachypnea [2]. Laboratory findings in dogs from* Correspondence: ulrika.falkeno@uds.slu.se
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reproduction in any medium, provided the orNorthwest Spain include moderate to severe regene-
rative anemia (hematocrit below 31%), with marked
reticulocytosis. Moderate to severe thrombocytopenia is
a common finding, with 50% of the dogs having platelet
counts below 23 × 109/L. Leukocytosis and evidence of
hepatic disease are uncommon. Azotemia has been
recorded in 10–36% of dogs infected with T. annae at
the time of diagnosis, which is a poor prognostic
marker, with a 22% fatality rate within a week post diag-
nosis [5,10,11].
T. annae appears as a small (less than 2 μm), single,
ring-shaped intraerythrocytic piroplasm in blood smears
from infected canids. Mostly, the parasitemia is of low
level [5,12]. Specific diagnosis of the parasite is con-
firmed by polymerase chain reaction (PCR) analysis of
blood samples. 18S RNA gene has been used for conven-
tional and nested PCR [5,6,11,12]. A reverse line blot
(RBL) assay has recently been developed that simultan-
eously detects and separates the major vector-borne dog
pathogens, including T. annae, in Southern Europe and
the Middle East [4].
T. annae appears to be resistant and poorly responds
to imidocarb dipropionate (Imizol, at 5–6.6 mg/kg)
[2,11]. Therefore, other drugs, such as Epoximicin and
Artesunate, are being investigated as potential therapeutics
[13,14]. T. annae infection in dogs has been hypothesized
to be lifelong [1]. Unless I. ricinus could serve as a vector,
T. annae is not likely to become endemic in Sweden
because of an absence of a suitable vector. However, globall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Hematology data from a puppy with proven
Theileria annae infection
Parameter Result Unit Reference
interval
Erythrocytes 1.2 × 1012/L (5.4-8.5)
Hemoglobin concentration 31 g/L (132–19)
Hematocrit 0.10 L/L (0.38-0.57)
Mean corpuscular volume 87 fl (64–74)
Mean corpuscular hemoglobin
concentration
298 g/L (335–363)
Red cell distribution width 25.2 % 10.6-14.3
Reticulocytes 271 × 109/L (11–111)
Leukocytes 20.8 × 109/L (5.8-16)
Segmented neutrophils 12.9 × 109/L (3.3-10.4)
Band neutrophils 1.7 × 109/L (0.0-0.5)
Lymphocytes 4.0 × 109/L (1.5-4.7)
Eosinophils 0.4 × 109/L (0.1-1.2)
Monocytes 1.9 × 109/L (0.1-1.0)
Note the reference values are for adult dogs and not for 12 week old, mixed
breed dogs.
Figure 1 Blood smear photomicrograph; Blood smear
photomicrograph with Giemsa stain illustrates anisocytosis, 2
polychromatophils and 1 erythrocyte with Theileria annae
(arrow). Original magnification 1000 ×.
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potentially change the distribution patterns of European
tick populations, potentially leading to spread of infectious
agents, such as T. annae, to Scandinavia.
The purpose of this first report of T. annae infection in
a dog in Scandinavia is to alert Scandinavian veterinarians
of the presence of this infection. It should be a differential
diagnosis in dogs with regenerative, hemolytic anemia.
This first case report of T. annae infection was a 12-week
old Swedish, part pit bull puppy with severe regenerative
anemia. It was unexpected to find this hemoprotozoan in
such a young, Swedish dog and the parasite species had
not been diagnosed in Scandinavia previously.
Case presentation
A 12-week-old, mixed pit bull, male dog was presented
to the University Animal Hospital of the Swedish Uni-
versity of Agricultural Sciences, January 2nd 2013, with a
history of suddenly appearing lethargic. The puppy was
acquired in Sweden four weeks previously and report-
edly was not in any contact with dogs which had trav-
eled out of Sweden. It had appeared normal and active
until the day before presentation. There was no history
of previous illness or medication. The dog had been
vaccinated at 8 weeks of age, presumably against canine
distemper, parvovirus and infectious canine hepatitis.
Physical examination indicated pale mucous membranes,
a mild holosystolic heart murmur, mild peripheral
lymphadenomegaly and suspected splenomegaly. The
owner did not reported any problem with the dog’s
mother.
A blood sample for complete blood count (CBC) was
collected in EDTA, and analyzed within two hours
(Advia 2120 hematology system, Siemens Healthcare
Diagnostics, Erlangen, Germany) and blood smears were
prepared, air-dried, stained with Giemsa and evaluated
microscopically (Table 1). Consequently, the dog was
diagnosed with a severe, moderately regenerative, mac-
rocytic, hypochromic anemia.
A small protozoan parasite was identified in approxi-
mately 2% of the erythrocytes. It was approximately 1–
2 μm in diameter and appeared as a dark dot (nucleus)
with a variable amount of visible cytoplasm (Figures 1
and 2). Based on its small size, and because B. gibsoni
was recorded previously in Sweden, the protozoan was
initially assumed to be B. gibsoni. No spherocytes,
autoagglutination or signs of oxidative damage such as
Heinz bodies or eccentrocytes were observed on blood
smear evaluation. There was no apparent hemolysis in
EDTA-plasma. The puppy had a mild neutrophilia with a
left shift indicating inflammation. The neutrophils did not
have any toxic changes. Platelet aggregates were observed
on blood smear examination, precluding an accurate auto-
mated platelet count, which recorded thrombocytopenia.Visual estimation from the blood smear suggested a mild
thrombocytopenia.
A sample for serum chemistry was also collected and
analyzed (Architect c4000, Abbott Laboratories, Abbott
Park, Illinois, USA). Serum chemistry analyses of hepatic
and renal parameters as well as albumin and protein
concentrations were unremarkable.
An EDTA blood sample was submitted to the Acarus
Laboratory, Molecular Diagnostic Unit, Langford Veter-
inary Services, Bristol, UK, for molecular identification
Figure 2 Giemsa stained blood smear photomicrograph;
Giemsa stained blood smear photomicrograph shows a
Theileria annae (arrows) in the two lower center erythrocytes
and one in the upper right polychromatophilic erythrocyte. The
lowest cell has a protozoon with more obvious cytoplasm. The
protozoa have a similar sized, dark, round nucleus. Original
magnification 1000 ×.
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100 μl of EDTA blood using the Nucleospin 8 Blood kit
(Machery-Nagel, Düren, Germany), according to the
manufacturer’s instructions, with elution into 100 μl
elution buffer. PCR was then performed using 1 X
Qiagen HotStarTaq Master Mix (Qiagen, Crawley, UK),
200nM each of primers (Metabion International AG,
Martinsried, Germany) designed to amplify a 450 base
pair (bp) product of the 18S rRNA gene of piroplasmas
(PiroA1 Forward 5′agg-gag-cct-gag-aga-cgg-cta-cc3′
and PiroB Reverse 5′tta-aat-acg-aat-gcc-ccc-aac3′), 5 μl
of DNA, made up to final volume of 25 μl with RNase
free water. PCR was carried out in a PTC-225 thermal
cycler (MJ Research, St. Bruno, Canada) with the following
protocol: 95°C 15 min, 40 × 95°C 15 sec, 60°C 20 sec and
72°C 30 sec. PCR products were analysed on a 1.5% Tris
acetate-EDTA agarose (Appleton scientific Molecular
Grade Agarose) gel with molecular weight markers
(BioLine Easy Ladder I, Bioline Reagents Ltd, London,
UK). Negative (sterile water) and positive (canine blood
confirmed to be infected with Babesia canis) controls were
also subjected to DNA extraction and PCR, and were ap-
propriately negative and positive. The PCR product pro-
duced using the DNA extracted from the puppy was then
purified using the Machery-Nagel Nucleospin Extract II
kit according to the manufacturer’s instructions and the
DNA quantified for sequencing using the InvitrogenQuant-iT dsDNA Assay kit & the Invitrogen Qubit
Flurometer according to manufacturer’s instructions.
Ten ng of purified PCR product was sent for DNA se-
quencing to DNA Sequencing & Services (Dundee, UK),
using the PiroA1 Forward and PiroB Reverse primers.
The sequence data derived was then BLAST searched
(337 bp with the forward primer, 316 bp with the reverse
primer) and showed 100% identity with canine T. annae
(JX454779.1 Genbank accession no.). There was no
evidence of other concurrent piroplasma infections.
The puppy was euthanized soon after initial diagnosis
at the owner’s request due to the potential for lifelong
infection. The owner declined a postmortem examin-
ation. Attempts to contact the dog breeder failed, but
Swedish health officials are still making efforts to trace
the origin of this infection.
Conclusions
To the authors’ knowledge this is the first case of T. annae
infection in Sweden.
This report should alert Scandinavian veterinarians
that T. annae infection in dogs should be included as
differential diagnosis in cases of regenerative anemia in
this region. We can hypothesize, based on the puppy’s
young age that the disease was transmitted vertically
from its mother. Additionally because T. annae may be
transmitted by bites from an infected dog and because
the patient was part pit bull terrier, a breed used for dog
fighting, we can also hypothesize the mother may have
been infected by a bite wound. However, information on
this possibility is not available.
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